HuR in Allergic Asthma
HuR in Allergic Asthma
批准号:
8070070
负责人:
ULUS ATASOY
金额:
$3.28万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-05-24 至 2010-09-30
关键词:
3&apos Untranslated RegionsAffectAllergensAllergic inflammationAnimal ModelAnimalsAreaAsthmaBindingBiologicalBiological AssayCD4 Positive T LymphocytesCell NucleusCloningComplexCytokine GeneCytoplasmDataDevelopmentDisabled PersonsDiseaseERG geneElementsEmployee StrikesExtrinsic asthmaFunctional disorderGene ExpressionGene Expression RegulationGenesGoalsHypersensitivityIL13 geneImmunoprecipitationIncidenceIndiumInflammatoryInflammatory ResponseInterleukin-13Interleukin-4Interleukin-5Knock-outLeadLentivirus VectorLungLymphocyteMediatingMessenger RNAMicroRNAsModalityModelingMusOperonOutcomeOvalbuminOvumPathogenesisPhenotypePlayPrevalenceProductionProteinsPublic HealthPublishingRNA-Binding ProteinsRegulationReportingResearchResearch PersonnelRoleSeveritiesT-Cell ActivationTestingTherapeuticTimeTissuesTransgenic MiceTranslationsUp-RegulationWorkallergic airway inflammationbasecDNA Arrayschemokinecytokinedesignexperiencegain of functionhandicapping conditionin vivoinnovationloss of functionnovel strategiespublic health relevanceresponse
中文摘要
描述(由申请人提供):由于未知原因,哮喘的患病率和严重程度一直在增加。尽管我们对哮喘的病理生理机制的理解仍然很差,但人们普遍认为哮喘是一种炎症性疾病,并且CD 4 + T细胞分泌Th 2细胞因子已被确定为其发展的主要罪魁祸首。这些基因中有许多是转录后调控的,但它们的调控还不清楚。我们已经发展了一种新的范式,转录后操纵子假说,即RNA结合蛋白协同调节生物相关分子的表达。我们的假设是,RNA结合蛋白,HuR,是协调调节Th 2极化和细胞因子基因表达在过敏性气道炎症。HuR是在其3'非翻译区含有富含Au的不稳定元件(战神)的不稳定mRNA的主要稳定剂。所有的Th 2细胞因子和90%的细胞因子和趋化因子都含有战神。1.确定HuR调节对淋巴细胞中Th 2极化和细胞因子产生的影响。我们将采用慢病毒载体在CD 4 + T细胞中低表达HuR,并测定Th 1/Th 2极化和细胞因子基因表达。2.确定HuR过表达和低表达在过敏性气道炎症小鼠模型中的作用。我们将在过敏性气道炎症的动物模型中测试改变HuR水平是否会改变哮喘的发展。3. HuR介导的过敏性炎症是否涉及microRNA?我们将使用阵列从卵致敏动物的肺中分离和鉴定microRNA。我们的方法将提供一个更全面的了解的身份和调节的促炎基因参与哮喘。在转录后水平更好地了解促炎基因调控可能会导致有针对性的治疗哮喘。公共卫生相关性:目前尚不清楚全球过敏和哮喘发病率和患病率增加的原因。在转录后基因调控和microRNA方面令人兴奋的新发现可能会对我们理解过敏原驱动的哮喘产生广泛的影响。该建议的目的是更好地了解细胞因子基因是如何在转录后水平上调节的。这将大大有助于我们了解疾病的发病机制和治疗方法,并对公共卫生产生直接影响。PHS 398/2590(Rev. 09/04)第15页
英文摘要
DESCRIPTION (provided by applicant): Asthma has been increasing in prevalence and severity for unknown reasons. Though our understanding of the pathophysiology remains poor, it is widely accepted that asthma is an inflammatory disease and CD4+ T cells elaborating Th2 cytokines have been identified as major culprits in its development. Many of these genes are posttranscriptionally regulated but their regulation is not well understood. We have developed a new paradigm, the posttranscriptional operon hypothesis, which states that RNA binding proteins are coordinately regulating the expression of biologically related molecules. Our hypothesis is that the RNA binding protein, HuR, is coordinately regulating Th2 polarization and cytokine gene expression in allergic airway inflammation. HuR is a major stabilizer of labile mRNAs containing AU rich instability elements (AREs) in their 3' untranslated regions. All the Th2 cytokines and 90% of cytokines and chemokines have AREs. 1. Determine effects of HuR modulation upon Th2 polarization and cytokine production in lymphocytes. We will employ lentiviral vectors to under-express HuR in CD4+ T cells and assay Th1/Th2 polarization and cytokine gene expression. 2. Determine role of HuR over-expression and under-expression in murine models of allergic airway inflammation. We will test whether altering HuR levels will modify asthma development in animal models of allergic airway inflammation. 3. Does HuR mediated allergic inflammation involves microRNAs? We will isolate and identify microRNAs from lungs of ova sensitized animals using arrays. Our approach will provide a fuller understanding of the identity and regulation of proinflammatory genes involved in asthma. Better understanding of proinflammatory gene regulation at the posttranscriptional level may potentially lead to targeted therapies to treat asthma. PUBLIC HEALTH RELEVANCE: The reasons for the increasing incidence and prevalence of allergies and asthma worldwide are presently unknown. Exciting new discoveries in posttranscriptional gene regulation and microRNAs potentially may have broad impacts on our understanding of allergen driven asthma. The aim of this proposal is to better understand how cytokine genes are regulated at the posttranscriptional level. This would greatly aid in our understanding of disease pathogenesis and treatment and have a direct impact on public health. PHS 398/2590 (Rev. 09/04) Page 15 Continuation Format Page
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of HuR Overexpression in Asthmatic Endotypes
-
批准号:10570322
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2023
-
负责人:ULUS ATASOY
-
依托单位:
Molecular mechanisms of posttranscriptional gene regulation in asthmatic airway inflammation
-
批准号:10698606
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2023
-
负责人:ULUS ATASOY
-
依托单位:
HuR in Allergic Asthma
-
批准号:8090588
-
项目类别:
-
资助金额:$22.02万
-
财政年份:2010
-
负责人:ULUS ATASOY
-
依托单位:
HuR in Allergic Asthma
-
批准号:7729032
-
项目类别:
-
资助金额:$28.33万
-
财政年份:2009
-
负责人:ULUS ATASOY
-
依托单位:
Posttranscriptional Gene Regulation in Asthma
-
批准号:7659902
-
项目类别:
-
资助金额:$20.21万
-
财政年份:2009
-
负责人:ULUS ATASOY
-
依托单位:
HuR in Allergic Asthma and T Cell Differentiation
-
批准号:9225152
-
项目类别:
-
资助金额:$18.8万
-
财政年份:2009
-
负责人:ULUS ATASOY
-
依托单位:
HuR in Allergic Asthma and T cell Differentiation
-
批准号:9590179
-
项目类别:
-
资助金额:$17.7万
-
财政年份:2009
-
负责人:ULUS ATASOY
-
依托单位:
HuR in Allergic Asthma
-
批准号:8107658
-
项目类别:
-
资助金额:$35.63万
-
财政年份:2009
-
负责人:ULUS ATASOY
-
依托单位:
Posttranscriptional Gene Regulation in Asthma
-
批准号:7847589
-
项目类别:
-
资助金额:$17.87万
-
财政年份:2009
-
负责人:ULUS ATASOY
-
依托单位:
HuR in Allergic Asthma and T Cell Differentiation
-
批准号:9021588
-
项目类别:
-
资助金额:$54.47万
-
财政年份:2009
-
负责人:ULUS ATASOY
-
依托单位:
HuR in Allergic Asthma
-
批准号:8307413
-
项目类别:
-
资助金额:$35.13万
-
财政年份:2009
-
负责人:ULUS ATASOY
-
依托单位:
HuR in Allergic Asthma
-
批准号:7912921
-
项目类别:
-
资助金额:$28.35万
-
财政年份:2009
-
负责人:ULUS ATASOY
-
依托单位:
ADA AND PREMATURE TERMINATION CODONS
-
批准号:2057320
-
项目类别:
-
资助金额:$8.66万
-
财政年份:1994
-
负责人:ULUS ATASOY
-
依托单位:
ADA AND PREMATURE TERMINATION CODONS
-
批准号:2057319
-
项目类别:
-
资助金额:$8.52万
-
财政年份:1994
-
负责人:ULUS ATASOY
-
依托单位:
ADA AND PREMATURE TERMINATION CODONS
-
批准号:2057317
-
项目类别:
-
资助金额:$8.48万
-
财政年份:1994
-
负责人:ULUS ATASOY
-
依托单位:
NIH INTRAMURAL NRSA INSTITUTIONAL TRAINING PROGRAM
-
批准号:3057547
-
项目类别:
-
资助金额:$3.08万
-
财政年份:1989
-
负责人:ULUS ATASOY
-
依托单位:
NIH INTRAMURAL NRSA INSTITUTIONAL TRAINING PROGRAM
-
批准号:3057546
-
项目类别:
-
资助金额:$2.6万
-
财政年份:1988
-
负责人:ULUS ATASOY
-
依托单位:
NIH INTRAMURAL NRSA INSTITUTIONAL TRAINING PROGRAM
-
批准号:3057545
-
项目类别:
-
资助金额:$2.5万
-
财政年份:1987
-
负责人:ULUS ATASOY
-
依托单位:
海外基金